Bestatin-amido-Me

Target: This ligand targets inhibitor of apoptosis proteins cIAP1, cIAP2, and XIAP through BIR domains in biochemical or cellular target-engagement studies.

Mechanism of Action: Used as the target-protein recognition element, this ligand provides the binding interface for inhibitor of apoptosis proteins cIAP1, cIAP2, and XIAP through BIR domains. In PROTAC design, a derivatizable position on the ligand can be connected through an optimized linker to an E3 ligase ligand, such as a CRBN, VHL, or IAP recruiter, while preserving productive target engagement. The resulting bifunctional molecule brings inhibitor of apoptosis proteins cIAP1 into proximity with the recruited E3 ligase, enabling ternary-complex formation. If the complex has favorable geometry and residence time, target lysine ubiquitination is promoted, leading to proteasome-dependent degradation in experimental systems.

• PROTAC Design for Aminopeptidases: Bestatin-amido-Me can serve as a high-affinity ligand module to build PROTACs targeting aminopeptidases. By conjugating this ligand to an E3 ligase recruiter through an optimized linker, researchers can probe ubiquitination efficiency, degradation potency, and selectivity across related protease family members in cellular degradation assays.

• Targeted Ubiquitination Studies: Incorporating Bestatin-amido-Me into PROTAC constructs enables systematic evaluation of how ligand engagement drives ternary complex formation and ubiquitination. This supports mechanistic studies using time-course immunoblotting, proteasome dependence controls, and competition experiments to distinguish degradation-driven effects from reversible inhibition.

• Linker Optimization for Degradation: The amide-linked Bestatin-amido-Me scaffold is suitable for exploring linker length, rigidity, and attachment geometry in PROTACs. Researchers can map structure–activity relationships to maximize target engagement, promote productive ubiquitin transfer, and reduce off-target degradation, using quantitative degradation metrics such as DC50 and maximal knockdown.

• Protease Network Profiling: PROTACs derived from Bestatin-amido-Me can be used to interrogate the functional contribution of aminopeptidase activity within protease networks. Degradation of the selected target can reveal downstream pathway changes, enabling pathway-level validation of substrate processing roles through transcriptomic or phosphoproteomic readouts.

Bestatin-amido-Me is an IAP-binding bestatin-derived building block for targeted protein degradation research. Its stereochemically defined hydroxyamide framework supports IAP recruitment when properly linked to a target ligand.

Structure: Bestatin-amido-Me is an IAP-binding bestatin-derived moiety containing a hydroxyamide core, primary amine, leucyl side chain, benzyl substituent, and terminal methyl amide. It contains several stereocenters and multiple hydrogen-bonding groups.

Reactivity: This compound is annotated as a PROTAC IAP-binding moiety and is therefore suited for E3 ligase recruitment. The primary amine or amide-associated vectors can be used in analogs for coupling to alkyl, PEG, amide, urea, or carbamate linkers connected to a selected target ligand. The hydroxyamide and stereochemical arrangement should be preserved because they are likely important for IAP binding.